Ethics and transparency

Cooperation with patient organizations

The patient comes first

For Bayer, one of the world's leading specialty pharmaceutical companies, patients' health always comes first. Exchanging ideas and information with patient organizations on the basis of mutual trust is an important component of our work.

Such cooperation helps us to understand the needs of patients as they come to terms with their illness. This enables us to gear our research and development to these needs and to continue working on improved, new drugs and therapies.

Bayer cooperates with patient organizations in all kinds of therapeutic areas. We attach great importance to transparency in this context and protect the independence of our cooperation partners.

Our principles

Cooperation between Bayer and patient organizations is based on the following principles.

  1. In order to provide patients with quality medical healthcare, a partnership with a patient organization pursues a specific objective concentrating on one or more of the following areas:
    • raising awareness for certain diseases by improving diagnostic possibilities and preventive measures, knowing the patients' prospects and needs,
    • understanding diseases and making sure that patients receive the best medical treatment available,
    • improving the information provided to the patients,
    • supporting medical innovations.
  2. Bayer and the patient organizations comply with international and national laws and regulations.
  3. Cooperation with a patient organization should neither influence decisions on a therapy nor promote or support specific therapies.
  4. Bayer respects the neutrality and independence of patient organizations. Cooperation is based on a partnership between equals in which transparency and clarity are fundamental principles. This is why we also provide information on the extent and nature of support.

Overview of cooperation with patient organizations in Europe in 2017

The following is a list of patient organizations with which Bayer and its affiliated companies in Europe cooperated in 2017.

Patient Organizations Country of Organization's Office Nature and Purpose of Support Value in Local Currency Value in Euro Travel costs in EURO
EURORDIS (European Rare Diseases Organisation) France One-year membership of the PO’s "Round Table of Companies"   5,000.00 no
European Pulmonary Hypertension Association (PHA Europe) Austria Support of PO in organizing World PH Day Award 2017 and associated activities   25,000.00 no
European Pulmonary Hypertension Association (PHA Europe) Austria Support of PO regarding the distribution of educational materials for patients on a novel nebulizing device "Breelib"   50,000.00 no
European Pulmonary Hypertension Association (PHA Europe) Austria Support of PO in organizing World PH Day 2017   100,000.00 no
European Society of Intensive Care Medicine (ESICM) Belgium Support of PO regarding their educational program "Pneumonia in the ICU"   30,000.00 no
Federation of European Scleroderma Associations (FESCA) Belgium Support of PO in organizing their World Scleroderma Day (WSD) June 29, 2017   25,000.00 no
International Agency for the Prevention of Blindness (IAPB) UK Support of PO regarding their World Sight Day Campaign 2017, October 13, 2017 40,000.00 USD 32,400.00 no
International Agency for the Prevention of Blindness (IAPB) UK Support of PO regarding their activities of the Universal Eye Health and VISION 2020. 100,000.00 USD 81,000.00 no
International Diabetes Federation (IDF) Belgium Support activities and core mission of PO in 2017 30,000.00 USD 24,300.00 no
International Diabetes Federation (IDF) Belgium Support activities of PO regarding their IDF Online Diabetes Education Module 165,000.00 USD 133,645.00 no
Stroke Alliance for Europe (SAFE) UK Support of PO in organizing the "Stroke Education and Training Programme", SAFE Working Conference and General Assembly December 2017   390,721.00 no
Country More Information
Austria Country website

Baltic States Reports can be received from UAB Bayer Baltic Republics (Estonia, Latvia, Lithuania) 
Alina Tikuišiene MD
Zirmunu str. 68A 
LT-09124 Vilnius/Lithunia
Belgium/Luxemburg (French) Country website
Belgium/Luxemburg (Dutch) Country website
Bulgaria Country website
Croatia Country website
Czech Republic Country website
Denmark Country website
Estonia Reports can be received from UAB Bayer Baltic Republics (Estonia, Latvia, Lithuania)
Alina Tikuišiene MD
Zirmunu str. 68A
LT-09124 Vilnius/Lithunia
Finland Country website
France Country website
Germany Country website
Greece Country website
Hungary Country website
Iceland Reports can be received from Bayer AB- Bayer Scandinavia
Iina Wargh
Gustav III:s Boulevard 56
169 26 Solna
Ireland Country website
Italy Country website
Latvia Country website
Lithuania Country website
Netherlands Country website
Norway Country website
Poland Country website
Portugal Country website
Romania Reports can be received from SC Bayer SRL
Bayer Pharmaceuticals Division
Sos. Pipera nr. 42., Sector 2
NUSCO Tower fl. 1,16,17
020112, Bucharest
Romania
Serbia Reports can be received from Bayer Pharma d.o.o. 
Jelena Tokanovic
Omladinskih brigada 88b
Belgrade
Slovenia Reports can be received from Bayer d.o.o. 
Lucija Zlodi Gosnik
Bravnicarjeva 13
1000 Ljubljana
Slovakia Country website
Spain Country website
Sweden Country website
Switzerland Country website
Turkey Country website
UK Country website
Ukraine Country website

Donations in Germany

Social responsibility is at the core of Bayer’s identity. For us, donations are an effective way of expressing this responsibility and engaging in social action. Bayer provides financial resources and donations of drugs and cash to support projects worldwide dealing with health and scientific research.

We have published a list of projects that Bayer and its cooperating companies supported with donations in 2015. We published this list in compliance with the code of conduct of the association Voluntary Self-Regulation of the Pharmaceutical Industry ("Freiwillige Selbstkontrolle für die Arzneimittelindustrie"). Since the legally required disclosures are specific German requirements, the list of projects is only available in German: http://www.gesundheit.bayer.de/de/engagement/patientenorganisationen/projekte/index.php